Trial Profile
Clinical Trials Insight: 700018500
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 May 2007
Price :
$35
*
At a glance
- Drugs NGD 4715 (Primary)
- Indications Obesity
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Neurogen Corporation
- 10 May 2007 Status change
- 16 Nov 2006 New trial record.